These results suggest that the sEH inhibitor AUDA may hinder the development of DCM by upregulating cardiomyocyte autophagy via Nrf2 upregulation and transcriptional activation of Nrf2. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.